NCNA: NuCana plc – Depositary Receipt (Common Stock) Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 14.89
Book Value / Share 0.28
Price / Book n/a
NCAV ($M) 12.10
NCAV / Share 0.23
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -2.30
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.91

Liquidity (mrq)
Quick Ratio 1.97
Current Ratio 1.97

Balance Sheet (mrq) ($M)
Current Assets 25.02
Assets 27.81
Liabilities 12.92
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-27 13D/A Sofinnova Venture Partners VIII, L.P. 11.90 -22.25
02-14 13G/A Griffith Hugh 11.00 20.97
01-26 13G/A Baillie Gifford & Co 6.98 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 188,193 1,033,059 18.22
2024-03-27 33,066 127,028 26.03
2024-03-26 111,481 457,965 24.34
2024-03-25 106,546 332,381 32.06

(click for more detail)

Similar Companies
AADI – Aadi Bioscience, Inc. ABEO – Abeona Therapeutics Inc.
ABIO – ARCA biopharma, Inc. ABVC – ABVC BioPharma, Inc.
ACB – Aurora Cannabis Inc.


Financial data and stock pages provided by
Fintel.io